Literature DB >> 21400558

MicroRNA-221 regulates FAS-induced fulminant liver failure.

Amar Deep Sharma1, Nidhi Narain, Eva-Maria Händel, Marcus Iken, Nishant Singhal, Toni Cathomen, Michael P Manns, Hans R Schöler, Michael Ott, Tobias Cantz.   

Abstract

UNLABELLED: Death receptor-mediated apoptosis of hepatocytes contributes to hepatitis and fulminant liver failure. MicroRNAs (miRNAs), 19-25 nucleotide-long noncoding RNAs, have been implicated in the posttranscriptional regulation of the various apoptotic pathways. Here we report that global loss of miRNAs in hepatic cells leads to increased cell death in a model of FAS/CD95 receptor-induced apoptosis. miRNA profiling of murine liver identified 11 conserved miRNAs, which were up-regulated in response to FAS-induced fulminant liver failure. We show that ectopic expression of miR-221, one of the highly up-regulated miRNAs in response to apoptosis, protects primary hepatocytes and hepatoma cells from apoptosis. Importantly, in vivo overexpression of miR-221 by adeno-associated virus serotype 8 (AAV8) delays FAS-induced fulminant liver failure in mice. We additionally demonstrate that miR-221 regulates hepatic expression of p53 up-regulated modulator of apoptosis (Puma), a well-known proapoptotic member of the Bcl2 protein family.
CONCLUSION: We identified miR-221 as a potent posttranscriptional regulator of FAS-induced apoptosis. miR-221 may serve as a potential therapeutic target for the treatment of hepatitis and liver failure.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400558     DOI: 10.1002/hep.24243

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Microsomal prostaglandin E synthase-1 protects against Fas-induced liver injury.

Authors:  Lu Yao; Weina Chen; Chang Han; Tong Wu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-21       Impact factor: 4.052

Review 2.  MicroRNA regulation of innate immune responses in epithelial cells.

Authors:  Rui Zhou; Steven P O'Hara; Xian-Ming Chen
Journal:  Cell Mol Immunol       Date:  2011-07-04       Impact factor: 11.530

Review 3.  MicroRNAs in injury and repair.

Authors:  Cory V Gerlach; Vishal S Vaidya
Journal:  Arch Toxicol       Date:  2017-05-13       Impact factor: 5.153

Review 4.  [Diagnosis and therapies for acute liver failure: scientific developments].

Authors:  M Ott; T Cantz; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

5.  MicroRNAs in Liver Disease: Bench to Bedside.

Authors:  Nihar Shah; James E Nelson; Kris V Kowdley
Journal:  J Clin Exp Hepatol       Date:  2013-09-17

Review 6.  Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.

Authors:  Li-Li Han; Yi Lv; Hui Guo; Zhi-Ping Ruan; Ke-Jun Nan
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

7.  Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection.

Authors:  Bin Yu; Ha Won Kim; Min Gong; Jingcai Wang; Ronald W Millard; Yigang Wang; Muhammad Ashraf; Meifeng Xu
Journal:  Int J Cardiol       Date:  2014-12-23       Impact factor: 4.164

Review 8.  MicroRNAs in liver disease.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-21       Impact factor: 46.802

Review 9.  MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

Authors:  Jie Sun; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  ScientificWorldJournal       Date:  2013-02-04

10.  Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.

Authors:  Minhua Rong; Gang Chen; Yiwu Dang
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.